Aanjaay Industries Limited (formerly Kabra Drugs Limited) has scheduled a Board of Directors meeting for September 2, 2026. The meeting will be held at the company’s corporate office in Chennai.

The primary agenda includes approving the Director’s Report and Corporate Governance Report for the financial year ended March 31, 2026. The board will also finalize logistics for the upcoming Annual General Meeting (AGM).

Key Agenda Items

The board will consider several administrative and governance matters during the session:

• Approve the closure of the Register of Members and Share Transfer Books for AGM purposes.
• Fix the date, time, and venue for the AGM and approve the draft notice.
• Appoint a scrutinizer for the AGM.
• Recommend the re-appointment of Mr. Kuniamuthur Nanjappan Anand as Director, who retires by rotation.
• Recommend the appointment of Ms. Moonam Kapoor as Director.
• Approve the appointment of Internal Auditors for FY27.
• Recommend the appointment of a Secretarial Auditor for the period FY27 to FY31.

Regulatory Compliance

The intimation is issued pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has requested BSE Limited to take this information on record.

Aanjaay Industries Limited (formerly known as Kabra Drugs Limited) returned to profitability in the first quarter of FY26, reporting a net profit after tax of ₹212.30 lakh. This marks a significant turnaround from the net loss of ₹49.98 lakh recorded in the same quarter of the previous fiscal year.

The Indore-based company posted total income from operations of ₹4,629.33 lakh for the quarter ended June 30, 2026, a substantial increase from ₹716.62 lakh in Q1FY25. The pre-tax profit stood at ₹284.01 lakh, unchanged from the figure before exceptional items.

For the full fiscal year FY26, Aanjaay Industries reported total operating income of ₹9,323.27 lakh and a net profit of ₹495.98 lakh. The equity share capital remained stable at ₹2,370.79 lakh throughout the periods reviewed.

What the Numbers Show

The divergence between the sharp rise in operating income and the relatively modest absolute profit figures suggests thin margins during the quarter. While revenue grew more than six-fold year-on-year, the net profit margin for the quarter stands at approximately 4.6% (₹212.30 lakh on ₹4,629.33 lakh), indicating that cost structures or lower-margin business mix may be absorbing much of the top-line growth. The absence of exceptional or extraordinary items confirms that the turnaround was driven purely by operational performance rather than one-off gains.

The company filed these unaudited financial results with stock exchanges pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were published in newspaper advertisements on August 18, 2026.